ChinaDaily Briefs

Daily Brief China: Alibaba Group Holding , China Resources Beverage, Midea Group Co Ltd A, Shuangdeng Group Co Ltd, SUNeVision Holdings, Duality Biotherapeutics, China Vanke and more

In today’s briefing:

  • When Dissenting REALLY Pays Off
  • CR Beverage IPO: The Bear Case
  • Midea Group (300 HK): Priced at Top End; Offer Size Adj Option Exercise Would Ease Index Fast Entry
  • Shuangdeng Group Pre-IPO Tearsheet
  • BUY/SELL/HOLD: Hong Kong Stock Updates (September 12)
  • Duality Biotherapeutics (映恩生物) Pre-IPO: Too Early, Too Ambitious
  • Morning Views Asia: Adaro Energy, China Vanke , Greentown China


When Dissenting REALLY Pays Off

By David Blennerhassett

  • Back in August 2017, Xingxuan Technology, a privately held Cayman Islands company operating in the online food delivery space in China, was transferred by way of a statutory merger. 
  • The buyer was Alibaba Group (9988 HK)-backed Rajax, the key seller, Baidu (9888 HK). The dissenter, having paid US$125mn for its shares, was offered cash/scrip worth an estimated US$42mn.
  • The dissenter considered terms low-balled. The judge agreed. The uplift? 659%.

CR Beverage IPO: The Bear Case

By Arun George

  • China Resources Beverage (CRB HK), China’s largest purified drinking water company, has received HK listing approval for a US$1 billion IPO.
  • In CR Beverage IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on core business’ pricing pressure, a slow pace of revenue diversification, a sizeable pre-IPO dividend, and margin and FCF generation below its key peer. 

Midea Group (300 HK): Priced at Top End; Offer Size Adj Option Exercise Would Ease Index Fast Entry

By Brian Freitas

  • Media reports indicate that Midea Group (000333 CH) has priced its H-shares IPO at HK$54.8/share, the top of the range. That is a 19.85% discount to the A-shares.
  • Reports also indicate that the IPO was oversubscribed multiple times with Hillhouse and GIC putting in large orders. That could result in the Offer Size Adjustment Option being exercised.
  • The exercise of the Offer Size Adjustment Option will take the IPO raise to HK$31bn (US$3.98bn) and index inclusion in some of the larger indices will become a lot easier.

Shuangdeng Group Pre-IPO Tearsheet

By Akshat Shah

  • Shuangdeng Group Co Ltd (JISHUZ CH) is looking to raise about US$150m in its upcoming Hong Kong IPO. The deal will be run by CICC, CCBI and Huatai.
  • Shuangdeng Group Co Ltd is engaged in energy storage business for big-data and telecommunication industries with a focus on design, R&D, manufacturing and sales of energy storage batteries and systems.
  • It was ranked first among global telecom base station and data-center energy storage battery providers in terms of shipment volume, achieving a 10.4% market share in 2023, according to F&S.

BUY/SELL/HOLD: Hong Kong Stock Updates (September 12)

By David Mudd

  • Hong Kong market is range bound with conglomerates showing strength over the last few weeks.  As the CNY/HKD strengthens the A/H premium should narrow.
  • SUNeVision Holdings (1686 HK) reported good results on the back of increased demand driven by the AI sector. 
  • Yum China Holdings (9987 HK),Yum China Holdings (YUMC US) reported flat sales and an increase in operating profit in a difficult fast food retail environment in China.

Duality Biotherapeutics (映恩生物) Pre-IPO: Too Early, Too Ambitious

By Ke Yan, CFA, FRM

  • Duality Biotherapeutics, a China-based clinical-stage biotechnology company, plans to raise up to US$300m via a Hong Kong listing.
  • In this note, we examine the company’s two core products, namely DB-1313 (HER2 ADC) and DB-1311 (B7-H3 ADC). We think the company’s products are not yet convincing.
  • While the management has expertise as biotech investors, biotech-related operational experience seems to be lacking.

Morning Views Asia: Adaro Energy, China Vanke , Greentown China

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars